Search

everythinglearnresearchcommunity

for

Search:↓

Cutaneous lupus can cause permanent hair loss by damaging hair follicles.

Skin problems are common in lupus, important for diagnosis, and can be triggered by sunlight.

The European Society of Cutaneous Lupus Erythematosus created a questionnaire to standardize patient assessment and improve care for cutaneous lupus.

The document concludes that recognizing and treating cutaneous lupus erythematosus early is crucial for managing the skin and potential systemic symptoms.

Most people with systemic lupus erythematosus have skin problems, and skin symptoms are often the first sign of the disease.

Lupus affects the body and skin, causing joint pain and skin issues that can be treated with steroids and antimalarial drugs.

Targeted cancer therapies often cause skin reactions, so dermatologists must manage these effects.

HIV can cause various severe or unusual skin conditions that help indicate the presence and stage of the disease.

The document concludes that treatment for cutaneous T-cell lymphoma should be customized to each patient's disease stage, balancing benefits and side effects, with no cure but many patients living long lives.

Hair follicle hyperplasia is common in both benign and malignant skin lymphoproliferative disorders, with a proposed new term "pseudolymphomatous adnexitis."

Some skin problems can be signs of diabetes or other metabolic diseases and recognizing them can help diagnose and treat these diseases early.

A woman with lupus experienced skin death due to a blood clotting disorder after stopping a blood thinner, which healed with treatment.

An 8-year-old girl had a rare, benign skin tumor on her forehead.

Any drug can cause skin reactions, but antibiotics, NSAIDs, and psychotropic drugs are more common, with some reactions being life-threatening.

New treatments and understanding of skin lupus are emerging in 2024.

The document concludes that Cutaneous Lupus Erythematosus has different forms, is influenced by genetic and environmental factors, and can be treated with various medications, but more targeted therapies are needed.

Cutaneous lupus erythematosus is a common skin condition in lupus, affecting mostly young adult females.

Damaged hair follicles make mice more prone to skin inflammation and skin cancer after UV exposure.

Some drugs, especially biologics, can cause skin reactions that look like other skin diseases, and stopping the drug usually helps clear up these reactions.

In Italian patients with lupus, the most common skin issue was chronic cutaneous lupus, especially discoid lesions, and nonspecific skin problems occurred in about a third of those with systemic lupus, mainly during active disease.

Skin problems are common and early signs of Systemic Lupus Erythematosus, and certain immune system markers are important for diagnosis and treatment.

Hair loss is common in lupus patients and can be permanent or reversible, depending on the type, with various treatments available.

The study found that Keratosis Pilaris Atrophicans is a genetic skin condition that starts in childhood, involves inflammation and scarring, and current treatments are only somewhat effective.

Laser hair removal may cause skin changes that prevent hair regrowth.

Papular mucinosis can cause eyebrow hair loss, but treatment can lead to regrowth.

Examining scalp tissue under a microscope helps diagnose and understand hair loss diseases.

High-dose ciclosporin significantly improved a young cat's severe skin condition.

Follicular mucinosis can be an early sign of aggressive mycosis fungoides.

Some patients with mycosis fungoides or Sézary syndrome experience hair loss, which may be similar to alopecia areata or linked to skin lesions, possibly due to abnormal T cells, and bexarotene can help treat it.

The document concludes that early diagnosis and treatment are crucial for managing rare hair loss disorders and that more research is needed to improve treatment strategies.